SCHEMBL7985238

SCHEMBL7985238

Cc1cccc(Cn2cnc3[nH]c(-c4ccc(N)cc4)nc(=O)c32)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
HPGD P15428 5/20 0.41
TSHR P16473 4/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPK14 Q16539 1/20 0.40
PARN O95453 1/20 0.39
CNOT7 Q9UIV1 1/20 0.39
ADORA2A P29274 3/20 0.39
ADORA1 P30542 2/20 0.39
ALOX15 P16050 1/20 0.39
MMP13 P45452 1/20 0.39
TNKS O95271 1/20 0.38
PARP1 P09874 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974270 0.92 ALDH1A1 (0.46) LMNAALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7991561 0.91 HPGD (0.43) LMNAALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7988570 0.91 HPGD (0.47) LMNAALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7988751 0.90 CNOT7 (0.43) LMNAALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7985065 0.87 CNOT7 (0.40) LMNACYP11B1CYP11B2TSHRHTT
SCHEMBL7975135 0.87 CNOT7 (0.52) ALDH1A1HPGDSMN1; SMN2PARNCNOT7
Hydrochloric Acid SCHEMBL7985519 0.86 CNOT7 (0.51) ALDH1A1HPGDSMN1; SMN2PARNCNOT7
SCHEMBL7974249 0.86 ALDH1A1 (0.41) LMNAALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7975243 0.86 HTT (0.44) LMNAALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7988962 0.86 GRIN1 (0.44) LMNAALDH1A1CYP11B1CYP11B2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed